TY - JOUR
T1 - Polyphenol intake and gastric cancer risk
T2 - Findings from the stomach cancer pooling project (stop)
AU - Vitelli-Storelli, Facundo
AU - Rossi, Marta
AU - Pelucchi, Claudio
AU - Rota, Matteo
AU - Palli, Domenico
AU - Ferraroni, Monica
AU - Lunet, Nuno
AU - Morais, Samantha
AU - López-Carrillo, Lizbeth
AU - Zaridze, David Georgievich
AU - Maximovich, Dmitry
AU - García, María Rubín
AU - Castaño-Vinyals, Gemma
AU - Aragonés, Nuria
AU - de la Hera, Manuela Garcia
AU - Hernández-Ramírez, Raúl Ulises
AU - Negri, Eva
AU - Bonzi, Rosella
AU - Ward, Mary H.
AU - Lagiou, Areti
AU - Lagiou, Pagona
AU - López-Cervantes, Malaquías
AU - Boffetta, Paolo
AU - Constanza Camargo, M.
AU - Curado, Maria Paula
AU - Zhang, Zuo Feng
AU - Vioque, Jesus
AU - La Vecchia, Carlo
AU - Sánchez, Vicente Martín
N1 - Publisher Copyright:
© 2020 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2020/10
Y1 - 2020/10
N2 - Phenolic compounds may exert a favorable effect on the risk of several cancer types, including gastric cancer (GC). However, selected polyphenol classes have not been adequately investigated in relation to GC. The aim of this study is to evaluate the association between the intake of polyphenols in relation to GC risk. We used data from the Stomach cancer Pooling (StoP) Project, including 10 studies from six countries (3471 GC cases and 8344 controls). We carried out an individual participant data pooled analysis using a two-stage approach. The summary odds ratios (ORs) of GC for each compound, and the corresponding 95% confidence intervals (95% CI), were computed by pooling study specific ORs obtained through multivariate logistic regression, using random effect models. Inverse associations with GC emerged for total polyphenols (OR = 0.67, 95% CI = 0.54–0.81, for the highest versus lowest quartile of intake), total flavonoids (OR = 0.73, 95% CI = 0.55–0.90), anthocyanidins (OR = 0.74, 95% CI = 0.56–0.92), flavanols (OR = 0.77, 95% CI = 0.66–0.88), flavanones (OR = 0.57, 95%CI = 0.44–0.69), total phenolic acids (OR = 0.75, 95%CI = 0.55–0.94), and hydroxybenzoic acids (OR = 0.73, 95%CI = 0.57–0.89). Results were consistent across strata of age, sex, social class, and smoking habit. Suggestive inverse associations were also found for flavonols (OR = 0.76, 95%CI = 0.51–1.01) and hydroxycinnamic acids (OR = 0.82, 95%CI = 0.58–1.06). Further investigations from longitudinal data are needed to confirm this association.
AB - Phenolic compounds may exert a favorable effect on the risk of several cancer types, including gastric cancer (GC). However, selected polyphenol classes have not been adequately investigated in relation to GC. The aim of this study is to evaluate the association between the intake of polyphenols in relation to GC risk. We used data from the Stomach cancer Pooling (StoP) Project, including 10 studies from six countries (3471 GC cases and 8344 controls). We carried out an individual participant data pooled analysis using a two-stage approach. The summary odds ratios (ORs) of GC for each compound, and the corresponding 95% confidence intervals (95% CI), were computed by pooling study specific ORs obtained through multivariate logistic regression, using random effect models. Inverse associations with GC emerged for total polyphenols (OR = 0.67, 95% CI = 0.54–0.81, for the highest versus lowest quartile of intake), total flavonoids (OR = 0.73, 95% CI = 0.55–0.90), anthocyanidins (OR = 0.74, 95% CI = 0.56–0.92), flavanols (OR = 0.77, 95% CI = 0.66–0.88), flavanones (OR = 0.57, 95%CI = 0.44–0.69), total phenolic acids (OR = 0.75, 95%CI = 0.55–0.94), and hydroxybenzoic acids (OR = 0.73, 95%CI = 0.57–0.89). Results were consistent across strata of age, sex, social class, and smoking habit. Suggestive inverse associations were also found for flavonols (OR = 0.76, 95%CI = 0.51–1.01) and hydroxycinnamic acids (OR = 0.82, 95%CI = 0.58–1.06). Further investigations from longitudinal data are needed to confirm this association.
KW - Diet
KW - Epidemiology
KW - Flavonoids
KW - Gastric cancer
KW - Polyphenols
UR - https://www.scopus.com/pages/publications/85093660472
U2 - 10.3390/cancers12103064
DO - 10.3390/cancers12103064
M3 - Article
AN - SCOPUS:85093660472
SN - 2072-6694
VL - 12
SP - 1
EP - 12
JO - Cancers
JF - Cancers
IS - 10
M1 - 3064
ER -